VISIPAQUE vs VISMODEGIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
VISIPAQUE vs VISMODEGIB: Safety Overview
| Metric | VISIPAQUE | VISMODEGIB |
|---|---|---|
| Total FAERS Reports | 136 | 8,135 |
| Deaths Reported | 3 | 864 |
| Death Rate | 2.2% | 10.6% |
| Hospitalizations | 40 | 974 |
| Average Patient Age | 58.0 yrs | 69.6 yrs |
| % Female Patients | N/A | 39.3% |
| FDA Approval Date | N/A | Jan 30, 2012 |
| Manufacturer | N/A | Genentech, Inc. |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |